Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and Syringe
| Status: | Completed |
|---|---|
| Conditions: | Diabetes, Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 40 - 99 |
| Updated: | 1/7/2017 |
| Start Date: | July 2005 |
| End Date: | September 2005 |
Comparison of the Accuracy and Precision of NovoLog® Mix 70/30 FlexPen® to Vial and Syringe in Patients With Type 2 Diabetes Mellitus
This trial is conducted in the United States of America (USA). The aim of this trial is to
compare desired (target) with actual target amounts of insulin dispensed using NovoLog® Mix
70/30 FlexPen® and vial and syringe in subjects with type 2 diabetes mellitus. No insulin is
administered in this trial - insulin is dispensed into an empty vial.
compare desired (target) with actual target amounts of insulin dispensed using NovoLog® Mix
70/30 FlexPen® and vial and syringe in subjects with type 2 diabetes mellitus. No insulin is
administered in this trial - insulin is dispensed into an empty vial.
Inclusion Criteria:
- Type 2 diabetes
- Insulin naive
- No previous experience administering injections
Exclusion Criteria:
- Any condition that, in the Investigator and/or Sponsor's opinion, could interfere
with the results of this trial
We found this trial at
1
site
Click here to add this to my saved trials
